[Op-Ed: Transformation] Merative Frees Truven from IBM

Microdosing
25/08/2022 19 min Temporada 5 Episodio 2

Listen "[Op-Ed: Transformation] Merative Frees Truven from IBM"

Descargar episodio Ver en sitio original

Episode Synopsis

While the healthcare community was chastising IBM for its Watson for Oncology solution last decade, what happened to the amazing healthcare data companies they acquired?  Well, they were set free this year, under the brand, Merative.  And what can we learn from the Watson Health days?

More episodes of the podcast Microdosing

Where Journeys Collide; Designing Beyond a Single Healthcare Experience Map 02/12/2025
The Monster in the Middle; Why Prior Authorization Wrecks the Patient Experience, and Why Everyone’s Trying to Tame It 29/11/2025
The Decentralizing of the Hospital Cafeteria; Why food service is the next frontier of healthcare innovation 18/11/2025
The Quiet Rebellion; How Small Medical Practices Are Beating the Odds and Finding Margin in the Chaos 04/11/2025
Medication Management and the Myth of Patient Empowerment 28/10/2025
Modern Primary Care Diagnostic Sequences 21/10/2025
The Next Safety Gap; How Compounded GLP-1s Expose the Limits of Oversight 14/10/2025
The Domino Effect; How Shifts in Medicaid and Medicare Advantage Reshape Everyone’s Insurance 07/10/2025
The 3 Ps Reshaping Care: Primary Care, Pricing, and Place 01/10/2025
America’s Only Unregulated Product; Firearms and the Public Health Gap 30/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA